Some patients with systemic mastocytosis have concurrent hematological neoplasms, designated in the World health Organization (WHO) classification as systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease (SM-AHNMD). …
Nature Genetics – Multiomic analysis of blast-phase myeloproliferative neoplasms identifies a chromosome 21 amplicon harboring DYRK1A as a clonal and therapeutically targetable event in around…
Nature Genetics – Multiomic analysis of blast-phase myeloproliferative neoplasms identifies a chromosome 21 amplicon harboring DYRK1A as a clonal and therapeutically targetable event in around…
Nature Genetics – Multiomic analysis of blast-phase myeloproliferative neoplasms identifies a chromosome 21 amplicon harboring DYRK1A as a clonal and therapeutically targetable event in around…
Search past winners and nominees, 1947 to the present. All Shows All In A Wonderful World: The Louis Armstrong Musical BOOP! The Musical Buena Vista…
After decades of state censorship and imprisonment, the Iranian director won the prestigeous Palme d’Or for best film with his highly political piece “It Was…
Sirenko et al. profile IDH1/2-mutated AML patients across disease stages (diagnosis, remission, and relapse) and treatments (targeted IDH inhibitors, chemotherapy, and hypomethylating agents). They delineate…
Sirenko et al. profile IDH1/2-mutated AML patients across disease stages (diagnosis, remission, and relapse) and treatments (targeted IDH inhibitors, chemotherapy, and hypomethylating agents). They delineate…
Key Points. A new clinical risk model in CMML, acronymized to BLAST, is easy to implement, globally applicable, and molecularly adaptiveMolecular informati
Nature – ADP-heptose binds to ALPK1, triggering transcriptional reprogramming and NF-κB activation, endowing pre-leukaemic cells with a competitive advantage due to excessive clonal…
Podcast Episode · The PathPod Podcast · 04/18/2025 · 53m
